DEA Announces New Requirements for Powerful Drugs, Aimed at Addressing Opioid Crisis

The Drug Enforcement Administration (DEA) announced on Friday that it will be reinstating federal requirements for powerful drugs such as OxyContin and Adderall. This comes after the requirements were waived when the COVID-19 pandemic began. The Biden administration is also proposing that patients must see a doctor in person before getting attention deficit disorder medication or addictive painkillers.

The proposal is expected to have a major impact on how millions of Americans get their prescriptions. This is because telehealth has been used for doctor’s appointments by computer or phone during the pandemic. The move is also seen as a way to address the opioid crisis that has been deepening in the United States.

The DEA said that the new requirements will help to ensure that patients are getting the right medications and that they are being used safely and effectively. The agency also said that the requirements will help to prevent the misuse and abuse of these powerful drugs.

The new requirements will go into effect in the coming months. The DEA said that it will be working with healthcare providers to ensure that they are aware of the new requirements and that they are able to comply with them.

The Biden administration’s move to require patients to see a doctor in person before getting attention deficit disorder medication or addictive painkillers is seen as an important step in addressing the opioid crisis. It is also expected to have a major impact on how millions of Americans get their prescriptions.